Ribonuclease 1 Induces T‐Cell Dysfunction and Impairs CD8<sup>+</sup> T‐Cell Cytotoxicity to Benefit Tumor Growth through Hijacking STAT1
Wenhao Yang(Fujian Agriculture and Forestry University), Mien‐Chie Hung(Precision Therapeutics (United States))
Cited by 5
Related Papers
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
|Cancer Cell|2004|1.9k
Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity
|Nature Communications|2016|1.1k
STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion
|Nature Communications|2018|427
IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion
|Journal of Clinical Investigation|2019|380
TYRO3 induces anti–PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis
|Journal of Clinical Investigation|2021|311